Integrated Advisors Network LLC Crispr Therapeutics Ag Transaction History

Integrated Advisors Network LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$51.17 - $68.18 $172,852 - $230,312	-3,378 Reduced 38.35%	5,430 $293,000
Q1 2024 May 03, 2024	BUY	$60.67 - $89.12 $67,040 - $98,477	1,105 Added 14.35%	8,808 $600,000
Q4 2023 Feb 26, 2024	BUY	$38.62 - $72.18 $19,310 - $36,090	500 Added 6.94%	7,703 $482,000
Q3 2023 Nov 16, 2023	BUY	$45.39 - $59.0 $326,944 - $424,977	7,203 New	7,203 $326,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Advisors Network LLC with notifications on news.